Acoustic Myography (AMG) Revolutionizes Concussion Baseline Testing in College Athletes
New Acoustic Myography Technology Offers Rapid, Non-Invasive Concussion Screening for Athletes
The NCAA requires member institutions to maintain Concussion Safety Protocols aligned with international consensus guidelines. These mandates cover neurocognitive testing, balance assessments, and symptom evaluation.
The NCAA Sport Science Institute does not endorse or certify specific commercial diagnostic devices. Individual university sports medicine teams may, however, incorporate SOFi as an optional biofeedback and monitoring tool during physical therapy and return-to-play progression, provided it does not replace required medical evaluations.
Why AMG Is a Gamechanger for College Concussion Care
AMG adds objective physiology to a field still dominated by subjective symptoms and cognitive testing. Its key strengths include:
- Objective data that cannot be gamed or influenced
- Portable and non-invasive with real-time results
- Detects subtle neuromuscular deficits that cognitive tests miss
- Tracks recovery trajectory with precision
- Aligns with the industry shift toward physiological biomarkers (e.g., EEG-based sideline tools)
“SOFi gives athletic trainers and physicians objective, real-time data on muscle function that symptom reports and cognitive tests simply cannot provide,” said a spokesperson for Advanced Myographic Technologies. “When used alongside established protocols, it helps identify athletes who may still be compensating even when they report feeling fine — supporting safer, more informed return-to-play decisions.”
College athletic programs interested in exploring SOFi as a complementary tool within their concussion management programs are encouraged to contact AMT for demonstrations and implementation guidance.
AMG is not intended to replace existing protocols but to enhance them at three critical junctures:
- Preseason Baseline (Healthy State)
- Post-Injury Comparison
- Return-to-Play Clearance
About Advanced Myographic Technologies (AMT)
AMT develops and provides the SOFi M²™ Acoustic Myography system, a non-invasive technology used to assess muscle function through acoustic signals. The company works with sports medicine professionals, athletic trainers, and rehabilitation specialists seeking objective data on neuromuscular performance and recovery.
Media & Business Contact
Advanced Myographic Technologies (AMT)
Phone: 352-456-8338 | Email: mail@myographytech.com
Web: www.myographytech.com
© 2026 Advanced Myographic Technologies, LLC. All rights reserved. SOFi M²™ is a trademark of AMT. This release is for informational purposes. Implementation of any adjunct technology should comply with institutional, NCAA, and medical guidelines.
